• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Are Drug Eluting Stents Worth Triple Therapy?药物洗脱支架值得三联疗法吗？
J Am Heart Assoc. 2017 Aug 21;6(8):e006983. doi: 10.1161/JAHA.117.006983.
2
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.药物洗脱冠状动脉支架置入患者的房颤患病率、治疗及 6 年随访结果。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1075-1085. doi: 10.1016/j.jcin.2017.02.028. Epub 2017 May 17.
3
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
Am Heart J. 2010 Sep;160(3):e21; author reply e23. doi: 10.1016/j.ahj.2010.06.016.
4
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时三联抗血小板治疗与双联抗血小板治疗的比较
Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15.
5
Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.SAFE-A研究的原理与设计：阿哌沙班联合双重抗血小板治疗在接受经皮冠状动脉介入治疗的房颤患者中的安全性和有效性试验
J Cardiol. 2017 Apr;69(4):648-651. doi: 10.1016/j.jjcc.2016.06.007. Epub 2016 Jul 18.
6
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting.接受冠状动脉支架置入术的房颤患者的抗血小板和抗栓治疗
Interv Cardiol Clin. 2017 Jan;6(1):91-117. doi: 10.1016/j.iccl.2016.08.007.
7
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).药物洗脱支架经皮冠状动脉介入治疗后高血小板反应性临床影响的性别差异：ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）结果
Circ Cardiovasc Interv. 2017 Feb;10(2). doi: 10.1161/CIRCINTERVENTIONS.116.003577.
8
Can We Improve Long-Term Outcomes Postbifurcation Stenting by Prolonged Dual Antiplatelet Therapy?延长双联抗血小板治疗能否改善分叉病变支架置入后的长期预后？
Circ Cardiovasc Interv. 2018 Jul;11(7):e006922. doi: 10.1161/CIRCINTERVENTIONS.118.006922.
9
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).外周动脉疾病患者冠状动脉植入药物洗脱支架后的血小板反应性及临床结局：来自ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）的分析
Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004904.
10
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

本文引用的文献

1
Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines.心房颤动合并急性心肌梗死患者的支架类型选择：ACTION（急性冠状动脉治疗和干预结果网络）注册研究-GET WITH THE GUIDELINES 的分析。
J Am Heart Assoc. 2017 Aug 21;6(8):e005280. doi: 10.1161/JAHA.116.005280.
2
Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者双联与三联抗栓治疗的安全性和疗效。
Am J Med. 2017 Nov;130(11):1280-1289. doi: 10.1016/j.amjmed.2017.03.057. Epub 2017 Apr 29.
3
Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗患者的慢性口服抗凝治疗及其相关结局
J Am Heart Assoc. 2016 Oct 17;5(10):e004310. doi: 10.1161/JAHA.116.004310.
4
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.2016年美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗时长的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告：2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南、2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南、2012年美国心脏病学会/美国心脏协会/美国内科医师学会/美国胸外科医师协会/美国预防心脏病学会/心血管造影和介入学会/美国胸外科医师学会稳定型缺血性心脏病患者诊断和管理指南、2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南、2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南以及2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南的更新
Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29.
5
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.药物洗脱支架置入术后需口服抗凝的患者三联治疗的持续时间：ISAR-TRIPLE 试验。
J Am Coll Cardiol. 2015 Apr 28;65(16):1619-1629. doi: 10.1016/j.jacc.2015.02.050.
6
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.药物洗脱支架和裸金属支架的安全性与有效性：随机试验和观察性研究的综合荟萃分析
Circulation. 2009 Jun 30;119(25):3198-206. doi: 10.1161/CIRCULATIONAHA.108.826479. Epub 2009 Jun 15.

Are Drug Eluting Stents Worth Triple Therapy?

作者信息

Heidenreich Paul

机构信息

VA Palo Alto Health Care System, Palo Alto, CA

出版信息

J Am Heart Assoc. 2017 Aug 21;6(8):e006983. doi: 10.1161/JAHA.117.006983.

DOI:10.1161/JAHA.117.006983
PMID:28862966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5586481/
Abstract
摘要